Description

Description:
Retatrutide 20 mg is a long-acting synthetic tri-agonist peptide that simultaneously targets the GLP-1, GIP, and glucagon receptors. This higher-dosage formulation is designed for advanced or long-duration studies requiring larger peptide quantities, enabling in-depth investigation of metabolic regulation, receptor cross-signaling, and energy expenditure. Its engineered structure includes lipidation and amino-acid modifications that enhance stability, receptor affinity, and bioavailability under laboratory conditions.

Research Applications:
Retatrutide 20 mg is utilized in preclinical and in vitro studies exploring:

• Multi-receptor peptide signaling across GLP-1, GIP, and glucagon pathways
• Mechanistic models of glucose metabolism and insulin regulation
• Lipid utilization and thermogenic energy balance
• Peptide optimization and structure–function correlation research

Molecular Formula: C₃₃₁H₅₁₂N₉₄O₉₉
Molecular Weight: ≈ 7476 g/mol
Sequence: H-His-Aib-Gln-Asp-Phe-Thr-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg-NH₂
(Includes proprietary lipidation and amino-acid substitutions for extended activity)

Form: Lyophilized powder
Purity: ≥ 98 % (HPLC)
Storage: Store at –20 °C. Avoid repeated freeze–thaw cycles.
Solubility: Soluble in sterile water or aqueous buffer

Handling and Use:
This compound is provided strictly for in vitro laboratory research. It is not intended for human consumption, veterinary use, or diagnostic applications. Standard aseptic and protective laboratory practices should be followed when handling all research peptides.